ESMO 2023: Immunotherapy Advancements in Bladder Cancer

home / insights / esmo-2023-immunotherapy-advancements-in-bladder-cancer

Following ESMO 2023, a panel of experts on bladder cancer review recent updates and discuss the evolving treatment landscape, with a focus on non–muscle invasive bladder cancer.

A panel of 4 experts on bladder cancer seated at a long table

EP. 1: Overview of Non–Muscle Invasive Bladder Cancer (NMIBC)

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
November 30th 2023

A panel of experts on bladder cancer provide an overview of the stratification, natural history, and treatment of bladder cancer.

A panel of 4 experts on bladder cancer seated at a long table

EP. 2: Treatment Considerations and Role of Trimodal Therapy in Bladder Cancer

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
November 30th 2023

Expert perspectives on treatment options available for patients with bladder cancer and the role of trimodal therapy.

A panel of 4 experts on bladder cancer seated at a long table

EP. 3: Monitoring Patients With NMIBC

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 7th 2023

The panel discusses strategies for monitoring patients with non–muscle invasive bladder cancer and the potential role of biomarkers.

A panel of 4 experts on bladder cancer seated at a long table

EP. 4: Bladder Cancer: Treatment Options and Managing Adverse Effects

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 7th 2023

Comprehensive insights on treatment considerations and managing immunotherapy-related adverse effects for patients with bladder cancer.

A panel of 4 experts on bladder cancer seated at a long table

EP. 5: Bladder Cancer: Highlights from ESMO 2023 and Ongoing Developments

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 15th 2023

The expert panel reviews highlights from ESMO 2023 and discusses ongoing developments in the treatment landscape for bladder cancer.

A panel of 4 experts on bladder cancer seated at a long table

EP. 6: Enfortumab Vedotin and the Role of ADCs in Bladder Cancer

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 15th 2023

Bladder cancer specialists discuss enfortumab vedotin and the role of antibody-drug conjugates in the treatment landscape.

A panel of 4 experts on bladder cancer seated at a long table

EP. 7: Approach to Collaborative Care in Bladder Cancer

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 21st 2023

The panel discusses the Large Urology Group Practice Association and provides insights on collaborative care approaches in bladder cancer.

A panel of 4 experts on bladder cancer seated at a long table

EP. 8: Key Takeaways on Evolving Bladder Cancer Treatment Landscape

Axel Merseburger, MD, PhD;M. Carmen Mir, MD, PhD;Shilpa Gupta, MD, Cleveland Clinic;Neal Shore, MD, FACS
December 21st 2023

The expert panel concludes its discussion by providing key takeaways on the evolving bladder cancer treatment landscape following ESMO 2023.